The Southern African Journal of Infectious Diseases (SAJID), formerly called the Southern African Journal of Epidemiology and Infection (SAJEI), first appeared in 1985 as a joint publication of the Infectious Diseases Society of Southern Africa (IDSSA), the Sexually Transmitted Diseases Society of Southern Africa (STDSSA) and the Epidemiology Society of Southern Africa, the latter having subsequently been succeeded by the Public Health Association of South Africa (PHASA). Presently SAJID is published under the auspices of the Federation of Infectious Diseases Societies of South Africa which is an umbrella organisation incorporating IDSSA, STDSSA as well as the Infection Control Society of South Africa (ICASA), the National Antibiotic Study Forum (NASF) of South Africa, and the South African Society of Travel Medicine (SASTM).

Publications of SAJID centre round aspects of epidemiology and infection, particularly those of importance to the societies of FIDSSA. Topics around infection include clinical and epidemiological aspects of communicable diseases, laboratory diagnosis of infections, characterisation of infective agents by molecular techniques and the study of transmission patterns of pathogens in institutional and community settings. Other infection related studies cover surveillance of vaccine-controllable and other infectious diseases, drug susceptibility patterns of hospital-acquired and community-acquired pathogens and infection control strategies for the southern Africa region. SAJID also promotes greater collaboration between clinically oriented and laboratory-based divisions within the FIDSSA societies, and the establishment of quality assurance programmes and other measures to enhance and maintain standards of diagnostic and public health microbiology.

Scientific papers in the SAJID aim to advance the understanding of all aspects of epidemiology, public health, clinical microbiology and infection. The journal strives to promote research and exchange of information on specific areas of infectious diseases, medical microbiology and virology, covering fields of interest of the societies of FIDSSA and PHASA. Manuscripts describing research performed at southern African institutions and in southern African settings enjoy a high priority, as do health matters covering Africa and the developing world, as well as global issues such as malaria and other tropical diseases, tuberculosis, sexually transmitted infections and HIV/AIDS. The scope of interest of SAJID is wide but the journal aims to maintain and improve the standard of its publications.

Skin protection range, Dexeryl, receives Allergy Foundation’s seal of approval

Partnership brings established international brand to South African consumers with complementary barrier and cleansing presentations for dry skins.

EXPERTS CALL FOR NATIONWIDE ADOPTION OF BUGWISE APP AMONG GPs TO KEEP ANTIBIOTIC RESISTANCE IN CHECK

Amid increased reporting of antibiotic resistance (ABR) worldwide, local health experts have called on South African doctors to more fully participate in and support efforts aimed at curbing the growing threat of antibiotic resistant superbugs in our country.

New Novartis South Africa CEO to continue building on partnerships

Novartis South Africa aims to continue building on local partnerships and health development initiatives, following the appointment of Dr. Mahomed (Mo) Kadwa as the company’s new Chief Executive Officer: Novartis South Africa and Head: Southern African Countries.

Warranties on medical devices could save the country – and taxpayers – millions in negligence claims

South Africa has a unique opportunity to become the global leader in the regulation of warranties for medical devices.

HONOURING SA DOCTORS WITH NATIONAL DOCTORS DAY

In recognition of the critical role that South African doctors play in the healthy functioning of South African society, 16 November has been declared national Doctors Day.

Wildcard SSL